Arkolith/Insider Trading/JAZZ/Form 4

Carr Patricia

SVP, Chief Accounting OfficerJazz Pharmaceuticals plc (JAZZ) · full profile →Form 4 · filed Mar 9, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$235K
Net Open-Market Flow
-$235K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 9, 2026Sell(S)1K$182.94$235K7K
Mar 5, 2026Tax withholding(F)1K$186.77$268K8K

Transaction Codes

S
Open-market sale
F
Shares withheld for taxes

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001784606-26-000012) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for Jazz Pharmaceuticals plc

Build

Ask your agent about JAZZ insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Get a key Compare plansForm 4 data
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001784606-26-000012"
Ask your agent
Use Arkolith to summarize insider buying and selling at Jazz Pharmaceuticals plc
over the last 90 days and cite the filings.